What is it about?
Newborn babies, especially premature and critically ill infants, respond to medicines differently from older children and adults because their organs and body systems are still developing. This publication explains the fundamental principles of neonatal clinical pharmacology, including how medicines are absorbed, distributed, metabolized, and eliminated in newborn infants. The work discusses the unique challenges of selecting appropriate medications, determining accurate drug doses, and preventing medication-related harm in neonatal care. It highlights the importance of developmental physiology, individualized dosing strategies, therapeutic drug monitoring, and careful evaluation of medicine safety in this highly vulnerable population. By translating complex pharmacological concepts into practical clinical approaches, this work aims to support healthcare professionals in providing safer and more effective treatment for newborn infants, ultimately contributing to improved neonatal outcomes worldwide.
Featured Image
Photo by Gabriel Dizzi on Unsplash
Why is it important?
Medication errors and inappropriate drug dosing remain significant concerns in neonatal intensive care because most medicines used in newborns were originally developed and studied in older populations. This publication addresses the critical need for a deeper understanding of developmental pharmacology and evidence-based prescribing in neonates. Its importance lies in emphasizing precision medicine approaches, safer prescribing practices, and individualized treatment based on the unique physiological characteristics of newborn infants. The knowledge presented may assist pediatricians, neonatologists, trainees, pharmacists, and other healthcare professionals involved in neonatal care to make more informed therapeutic decisions and improve patient safety.
Perspectives
As a pediatrician and neonatologist with extensive clinical experience in neonatal and pediatric practice, I have witnessed the challenges clinicians face when prescribing medicines for newborn infants. Neonates are not simply smaller versions of adults; their rapidly changing physiology requires a specialized understanding of drug therapy. My motivation for writing this publication was to bridge the gap between pharmacological science and everyday neonatal practice by providing a practical, evidence-informed overview of safe drug use in newborns. I hope this work contributes to ongoing education, promotes rational prescribing, and supports healthcare professionals worldwide in delivering safer and more effective neonatal care.
DR ATIQUR RAHMAN KHAN
Royal College of Physicians and Surgeons of Glasgow
Read the Original
This page is a summary of: Neonatal Clinical Pharmacology: Principles, Dosing, and Safe Drug Use in the Newborn, March 2026, Deep Science Publishing,
DOI: 10.70593/978-93-7185-306-4.
You can read the full text:
Contributors
The following have contributed to this page
